Amentadione is a new modulating agent for osteoarthritis in an ex-vivo co-culture preclinical assay by Araujo, Nuna C. P. et al.
Full Terms & Conditions of access and use can be found at
https://www.tandfonline.com/action/journalInformation?journalCode=iann20
Annals of Medicine
ISSN: 0785-3890 (Print) 1365-2060 (Online) Journal homepage: https://www.tandfonline.com/loi/iann20
Amentadione is a new modulating agent for
osteoarthritis in an ex-vivo co-culture preclinical
assay
Nuna Araújo, Carla Viegas, Inês Perrolas, Rúben Costa, Joana Magalhães,
Francisco Blanco, Acácio Ramos, Maria Miguel, Cees Vermeer, Eva Zubía &
Dina Simes
To cite this article: Nuna Araújo, Carla Viegas, Inês Perrolas, Rúben Costa, Joana Magalhães,
Francisco Blanco, Acácio Ramos, Maria Miguel, Cees Vermeer, Eva Zubía & Dina Simes (2019)
Amentadione is a new modulating agent for osteoarthritis in an ex-vivo co-culture preclinical assay,
Annals of Medicine, 51:sup1, 43-43, DOI: 10.1080/07853890.2018.1561895
To link to this article:  https://doi.org/10.1080/07853890.2018.1561895
Published online: 28 May 2019.
Submit your article to this journal 
Article views: 14
View related articles 
View Crossmark data
Amentadione is a new modulating agent for osteoarthritis in an ex-vivo
co-culture preclinical assay
Nuna Araujoa, Carla Viegasa,b, Inês Perrolasa, Ruben Costaa, Joana Magalh~aesc, Francisco Blancoc,
Acacio Ramosd, Maria Migueld, Cees Vermeere, Eva Zubıaf and Dina Simesa,b
aCentre of Marine Sciences (CCMAR), University of Algarve, Faro, Portugal; bGenoGla Diagnostics,CCMAR, University of Algarve, Faro,
Portugal; cGrupo de Bioingenierıa Tisular y Terapia Celular, Instituto de Investigacion Biomedica de A Coru~na, Complejo Hospitalario
Universitario de A Coru~na, Sergas Universidad de A Coru~na, A Coru~na, Spain; dDepartment of Orthopaedics and Traumatology,
Hospital Particular do Algarve, Gambelas-Faro, Portugal; eR&D Group VitaK, Maastricht University, 6229 EV Maastricht, The
Netherlands; fDepartment of Organic Chemistry, Faculty of Marine and Environmental Sciences, University of Cadiz, Puerto Real
(Cadiz), Spain
Introduction: Osteoarthritis (OA) is a whole-joint disease where inflammation interplays with extracellular matrix mineral-
ization in a cycle that leads to its degradation. The lack of effective preventing treatments and disease modifying agents,
demands new therapeutic targets and development of effective drugs. Amentadione (YP), a meroditerpenoid extracted
from the alga Cystoseira usneoides was previously shown to have anti-inflammatory and antioxidant activities [1]. The
main purpose of this study was to develop a close-to-the-in-vivo OA model, to evaluate the potential and mode of action
of novel therapeutic agents. Also, we aim to evaluate the potential of YP as a novel therapeutic agent for OA, using the
developed 3D OA model.
Materials and methods: Monocultures of articular cells [2], cartilage ex vivo explants and co-cultures of cartilage explants
with synoviocytes, were treated with YP and subjected to inflammatory/mineralizing conditions. OA gene markers and
inflammatory mediators were analysed by qPCR and ELISA. Histological evaluation of cartilage explants was performed by
von Kossa/hematoxylin and Alcian blue staining.
Results: YP was shown to reduce the inflammatory response in the articular primary cell system when subjected to min-
eralizing and inflammatory conditions. After establishment and characterization of an ex vivo OA co-culture model, YP
was confirmed to be able to reduce the expression of OA gene markers of inflammation, cell differentiation, and matrix
degradation (COX-2, IL-6, Col10, Runx2, MMP3) following stimulation with hydroxyapatite and IL1-b.
Discussion and conclusions: YP pre-treatment of OA culture model systems resulted in a significant downregulation of
inflammatory, differentiation, and extracellular matrix-related genes and reduced the levels of inflammatory cytokines.
These results clearly indicate a protective effect of YP on cartilage degradation with high potential for OA therapeutic
application.
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